Innovative Nanopharmaceuticals: Targeting Breast Cancer Stem Cells by a Novel Combination of Epigenetic and Anticancer Drugs with Gene Therapy

News

 

The project was completed on 30.6.2021

 

The INNOCENT 5th Partner Assembly

Date & Time
TC September 9th, 2020

 

 

The project was extended by 1 year until the end of 2020

 

The INNOCENT 4th Partner Assembly

Slovak Academy of Sciences Congress Centre,
Smolenice Castle

Date & Time
September 25-27th 2019

The objective of the meeting is to review our recent progress in the development of nanocarrier, to discuss the findings and to harmonise work of individual research groups. Plans for the next half a year period will be discussed.

Each work package leader is requested to present an overview of progress and plans towards the next 6 months, relevant to particular tasks.

 

The INNOCENT 3rd Partner Assembly

Latvian Institute of Organic Synthesis
Aizkraukles 21, LV-1006, Riga, Latvia

Date & Time
Tuesday, 16 April 2019

The informal program will start on Monday, 15 April 2019
City walk at 5pm
Common dinner at 6:30pm
Cafe Lidojošā varde (the Flying frog)
Elizabetes iela 31 a, Rīga, LV-1010

The objective of this meeting is to review our recent progress, to discuss the results, to harmonise work of individual research groups and to prepare detailed plans for the next period. Each work package leader is requested to present an overview of progress and plans towards the M32 relevant to particular tasks.

 

The INNOCENT 2nd Partner Assembly

took place at Vall Hebron Institut Recerca, Collserola Building – Auditorium Sala Cursos, Barcelona

Date & Time
Wednesday 31th October 2018

Attendees
Victor Puntes, Eudald Casals, Muriel Freixanet Gusta (VHIR), Bozena Smolkova, Svetlana Miklikova, Alena Gabelova (BMC SAS), Aiva Plotniece, Pajuste Karlis, Pavels Dimitrijevs (LIOS), Ivan Rios Mondragon (UiB), Alexandra Misci Hudecova (WP 3, NILU – via Skype)

AGENDA

9.00-9.30h Welcome and Overview by coordinator
9.30-12.00h SCIENTIFIC AND TECHNINAL PROGRESS. Presentations from each work package leader. Each work package leader presented an overview of progress on scientific work, including achievements since 5 May 2018, and plans towards the M24 (1 April 2019).
  • WP1: Synthesis of nanocarriers - LIOS
  • WP2: Detailed characterization – VHIR
  • WP3: Hazard and risk assessment of the nanocarriers – UiB
  • WP4: Drug treatment in vitro – CRI
  • WP5: Drug treatment in vivo – CRI
12.00-13.00h LUNCH
13.00-15.30h ROUND TABLE DICUSSION
  • Discussion on nanocarrier (COMBOBOMB)
  • Discussion on therapeutic model and biodistribution
  • Discussion on technical problems and possible solutions
15.30-16.00h BREAK
16.00-16.30h DISCUSSION ON DELIVERABLES AND COMMUNICATION
16.30-17.30h CONCLUSIONS AND FUTURE DEVELOPMENT
17.30-18.00h MEETING CLOSURE

 

INNOCENT 3rd Partner Assembly
Wednesday 31th October 2018

 

The INNOCENT annual meeting will take place at the Cancer Research Institute BMC SAS, Dúbravská cesta 9, Bratislava, Slovakia.

Date & Time
Wednesday, May 09, 2018

Official programme will start at 09:00 a.m. (CET). All participants are invited for common dinner on Tuesday, May 08, 2018 at 06:00 p.m.

The objective of the first annual meeting is to review our recent progress, to discuss the results, to harmonise work of individual research groups, to clarify/specify tasks and prepare detailed plans for the next period. Participants are requested to prepare presentations with summary of individual group achievements and highlight future research plans relevant to the particular tasks.

Send response to: bozena.smolkova@savba.sk and in cc to: lucia.kucerova@savba.sk

Kick-Off Meeting

The INNOCENT kick-off meeting will take place at the Cancer Research Institute BMC SAS, Dúbravská cesta 9, Bratislava, Slovakia.

Date & Time
Tuesday, 21 – Wednesday, March 22, 2017

The programme will start on Tuesday 21 at 13:00/1 p.m. (CET).

The objective of this meeting is to clarify/specify and work out the detailed plans of individual research groups during the project implementation. Participants will be engaged in interactive discussions of their activities and priorities during the first 12 months and main research questions of the project. Outputs of the workshop will serve as basis for the cooperation of the future research. Participants are requested to work out plans to initiate discussion about the topics of the research groups.

This meeting will also be a good opportunity to get to know each other and to exchange first views. Kindly confirm whether you wish to attend the meeting by giving the written notice no later than February 10, 2017.

Send response to: lucia.kucerova@savba.sk, and in cc to: bozena.smolkova@savba.sk; svetlana.skolekova@savba.sk

The project has received founding from the 7th Joint Transnational Call for Proposals for "European Innovative Research & Technological Development Projects in Nanomedicine" within the framework of the ERA-NET EuroNanoMed-II.